Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis

BACKGROUND: A combination therapy with inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA) is recommended in severe chronic obstructive pulmonary disease (COPD) patients experiencing frequent exacerbations. Currently, there are five ICS/LABA combination products available on the marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Oba, Yuji, Lone, Nazir A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026563/
https://www.ncbi.nlm.nih.gov/pubmed/24872685
http://dx.doi.org/10.2147/COPD.S48492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026563/
https://www.ncbi.nlm.nih.gov/pubmed/24872685
http://dx.doi.org/10.2147/COPD.S48492

Ejemplares similares